Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APC-100 in Advanced Prostate Cancer
NCT01436214Phase 2Unknown
- Sponsor
- DMK Pharmaceuticals Corporation
- Start
- Aug 2011
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pentamethylchromanol in prostate cancer (PCa), sponsored by DMK Pharmaceuticals Corporation. Status: unknown.
02
Drugs
pentamethylchromanol
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01436214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01436214.